Table 1.
Subgroup A1 (n = 2)∗ | Subgroup A2 (n = 2) | Subgroup A3 (n = 2) | Subgroup A4 (n = 2) | Subgroup A5 (n = 1) | Subgroup A6 (n = 1) | Subgroup A7 (n = 1) | Subgroup A8 (n = 1) | |
---|---|---|---|---|---|---|---|---|
Period 1 | Glucose | Starch + TZQ | Maltodextrin + TZQ | Sucrose + TZQ | Maltose + TZQ | Glucose + TZQ | Glucose | Glucose |
Period 2 | Glucose | Glucose | Starch + TZQ | Maltodextrin + TZQ | Sucrose + TZQ | Maltose + TZQ | Glucose + TZQ | Glucose |
Period 3 | Glucose | Glucose | Glucose | Starch + TZQ | Maltodextrin + TZQ | Sucrose + TZQ | Maltose + TZQ | Glucose + TZQ |
Period 4 | Glucose + TZQ | Glucose | Glucose | Glucose | Starch + TZQ | Maltodextrin + TZQ | Sucrose + TZQ | Maltose + TZQ |
Period 5 | Maltose + TZQ | Glucose + TZQ | Glucose | Glucose | Glucose | Starch + TZQ | Maltodextrin + TZQ | Sucrose + TZQ |
Period 6 | Sucrose + TZQ | Maltose + TZQ | Glucose + TZQ | Glucose | Glucose | Glucose | Starch + TZQ | Maltodextrin + TZQ |
Period 7 | Maltodextrin + TZQ | Sucrose + TZQ | Maltose + TZQ | Glucose + TZQ | Glucose | Glucose | Glucose | Starch + TZQ |
Period 8 | Starch + TZQ | Maltodextrin + TZQ | Sucrose + TZQ | Maltose + TZQ | Glucose + TZQ | Glucose | Glucose | Glucose |
∗The influences of 3-, 6-, and 9-tablet TZQ on the blood glucose levels were evaluated following the oral administration of the carbohydrates to subjects in the low-dose group, middle-dose group, and high-dose group, respectively.